Old Web
English
Sign In
Acemap
>
authorDetail
>
Markus Puhlmann
Markus Puhlmann
Amgen
Pathology
Medicine
Angiogenesis
Angiopoietin receptor
Vascular endothelial growth factor
2
Papers
94
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AMG 386 in Combination With Sorafenib in Patients With Metastatic Clear Cell Carcinoma of the Kidney: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study
2012
Cancer
Brian I. Rini
Cezary Szczylik
Nizar M. Tannir
P. Koralewski
Piotr Tomczak
Andrzej Deptala
Luc Dirix
Mayer Fishman
Rodryg Ramlau
Alain Ravaud
Wojciech Rogowski
Karolyn Kracht
Yu-Nien Sun
Michael B. Bass
Markus Puhlmann
Bernard Escudier
Show All
Source
Cite
Save
Citations (92)
Phase Ib study of AMG 386 in combination with paclitaxel (P) and carboplatin (C) in high-risk stage I and stages II-IV epithelial ovarian, primary peritoneal, or fallopian tube cancers.
2012
Journal of Clinical Oncology
Antonio Casado
Ana Oaknin
Jean-François Baurain
Shirley Wong
Xinqun Yang
Benjamin Wu
Zhandong Don Zhong
Markus Puhlmann
Ignace Vergote
Show All
Source
Cite
Save
Citations (2)
1